Jun 10, 2020
Menarini Group Completes a Solid Year of Operating Performance
Jun 10, 2020
Menarini Silicon Biosystems Begins Distribution of Rapid COVID-19 Antibody Test in North America
May 14, 2020
25th EHA Congress: Menarini Ricerche Discloses First Results From the Clinical Study on SEL24/MEN1703
Apr 27, 2020
Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19
Mar 16, 2020
Covid-19: Menarini Group Converts Production Plant to Produce and Donate Disinfectant Gel
Feb 27, 2020
Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy in Clinical Research
Dec 09, 2019
61st ASH Congress 2019: Menarini Ricerche Presents the Latest Updates About the First In Human Clinical Trial of SEL24/MEN1703
Dec 09, 2019
New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium
Oct 30, 2019
Menarini Silicon Biosystems to Debut VRNxT Technology at 25th Annual Meeting of the Association for Molecular Pathology
Sep 23, 2019
ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer
Jul 17, 2019
Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument
Jun 28, 2019
Menarini Ricerche Announces Publication of Pre-clinical Data of the First-in-class Antibody-drug Conjugate MEN1309/OBT076, Currently in Phase I Clinical Development
May 23, 2019
Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology
Mar 05, 2019
Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells
Dec 21, 2018
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat
Nov 29, 2018
New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium
Nov 27, 2018
Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting
Oct 29, 2018
Menarini Silicon Biosystems Introduces New DEPArray SamplePrep Kit for Analysis of FFPE Tissue Samples
Oct 19, 2018
Menarini Progresses Into the Clinic With MEN1611, a PI3K Inhibitor for the Treatment of HER2 Positive Metastatic Breast Cancer
Oct 12, 2018
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries